课题基金 / 基金详情

Analysis of Cartilage Morphology and sGAG Content via Contrast Enhanced Micro-CT

Analysis of Cartilage Morphology and sGAG Content via Contrast Enhanced Micro-CT
通过增强显微 CT 分析软骨形态和 sGAG 含量
批准号:
7230164
负责人:
ROBERT E GULDBERG
金额:
$15.73万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2010-04-30

项目摘要

项目成果

ROBERT E GULDBERG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Osteoarthritis (OA) is a potentially debilitating condition of articular joints characterized by a gradual but progressive degradation of the cartilage extracellular matrix. Interest in OA pathogenesis and in models for testing disease modifying therapies has motivated the development of numerous small animal models for joint degeneration. However, while matrix changes in such models can be evaluated via histology and gross biochemical analysis, determination of detailed spatial information regarding matrix changes is challenging at best. A technique capable of high resolution, nondestructive quantification of cartilage morphology and matrix composition could revolutionize the evaluation of such small animal models. The goal of this Exploratory/Developmental Research Grant proposal is to develop a novel imaging methodology utilizing contrast-enhanced microcomputed tomography (UCT) to obtain high resolution, three-dimensional (3D) data describing the morphology and sulfated glycosaminoglycan distribution of small animal articular cartilage. While a powerful tool for quantitative morphological and microstructural analysis of bone and a variety of biomaterials, UCT has not been useful for analysis of cartilage or other soft tissues because of their minimal X-ray attenuation. We have recently performed preliminary validation of a novel UCT application for quantification of the Equilibrium Partitioning of an Ionic Contrast agent UCT (EPIC-UCT) that relies on preferential exclusion of a negatively charged, radio-opaque contrast agent from tissue regions with a greater negative fixed charge density (primarily due to sulfated glycosaminoglycans (sGAGs) on proteoglycans). The specific aims of the proposed research are to (1) evaluate the use of EPIC-UCT to quantify the morphology of rat articular cartilage; (2) evaluate the use of EPIC-UCT to quantify the sGAG distribution of rat articular cartilage; and (3) evaluate the use of EPIC-UCT for in situ evaluation of articular cartilage in intact rat knees using direct intraarticular injection of the contrast agent. In this 2-year project, we aim to develop a methodology suitable for end-stage analysis of articular cartilage in small rodent models and to have laid the groundwork for studies extending this methodology to longitudinal, in vivo tracking of cartilage matrix changes.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.joca.2008.07.015
发表时间: 2009-03
期刊: Osteoarthritis and cartilage
影响因子: 7
作者: [Xie L, Lin AS, Levenston ME, Guldberg RE]
通讯作者: Guldberg RE
DOI: 10.1002/art.34370
发表时间: 2012-06
期刊: ARTHRITIS AND RHEUMATISM
影响因子: --
作者: [Xie, LiQin, Lin, Angela S. P., Kundu, Kousik, Levenston, Marc E., Murthy, Niren, Guldberg, Robert E.]
通讯作者: Guldberg, Robert E.
DOI: 10.1016/j.joca.2009.07.014
发表时间: 2010-01
期刊: OSTEOARTHRITIS AND CARTILAGE
影响因子: 7
作者: [Xie, L., Lin, A. S. P., Guldberg, R. E., Levenston, M. E.]
通讯作者: Levenston, M. E.
Quantitative pre-clinical screening of therapeutics for joint diseases using contrast enhanced micro-computed tomography.
使用对比增强微计算机断层扫描对关节疾病的治疗方法进行定量临床前筛选。
DOI: 10.1016/j.joca.2016.04.021
发表时间: 2016
期刊: Osteoarthritis and cartilage
影响因子: 7
作者: [Willett,NJ, Thote,T, Hart,M, Moran,S, Guldberg,RE, Kamath,RV]
通讯作者: Kamath,RV
Immunoengineering Strategies for Musculoskeletal Trauma
  • 批准号:
    9974169
  • 项目类别:
  • 资助金额:
    $51.63万
  • 财政年份:
    2020
  • 负责人:
    ROBERT E GULDBERG
  • 依托单位:
Immunoengineering Strategies for Musculoskeletal Trauma
  • 批准号:
    10155430
  • 项目类别:
  • 资助金额:
    $48.26万
  • 财政年份:
    2020
  • 负责人:
    ROBERT E GULDBERG
  • 依托单位:
Immunoengineering Strategies for Musculoskeletal Trauma
  • 批准号:
    10448258
  • 项目类别:
  • 资助金额:
    $49.25万
  • 财政年份:
    2020
  • 负责人:
    ROBERT E GULDBERG
  • 依托单位:
Immunoengineering Strategies for Musculoskeletal Trauma
  • 批准号:
    10612470
  • 项目类别:
  • 资助金额:
    $49.75万
  • 财政年份:
    2020
  • 负责人:
    ROBERT E GULDBERG
  • 依托单位:
海外基金